Template:Map/Ether phospholipid: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 11: | Line 11: | ||
|style="text-align:center;"|1-acyl dihydroxy acetone p | |style="text-align:center;"|1-acyl dihydroxy acetone p | ||
|{{Map/ReactionLeftRight|NADH|NAD+|[http://metabolomics.jp/wiki/Enzyme:1.1.1.8 1.1.1.8]}} | |{{Map/ReactionLeftRight|NADH|NAD+|[http://metabolomics.jp/wiki/Enzyme:1.1.1.8 1.1.1.8]}} | ||
|style="text-align:center;"|1-acyl ''sn''-glycerol 3p<br/>[[Image: | |style="text-align:center;"|1-acyl ''sn''-glycerol 3p<br/>[[Image:LBG1C3P.png]] | ||
|- | |- | ||
|{{Map/ReactionDown35inout|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p<ref>アルキル型を含むエーテルリン脂質はペルオキシソームで合成。ペルオキシソームを欠乏するZellweger症候群では血小板活性化因子PAFが著しく減少。</ref>{{Map/ReactionDown35inout|NADPH|<small>→NADP+</small>|}} | |{{Map/ReactionDown35inout|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p<ref>アルキル型を含むエーテルリン脂質はペルオキシソームで合成。ペルオキシソームを欠乏するZellweger症候群では血小板活性化因子PAFが著しく減少。</ref>{{Map/ReactionDown35inout|NADPH|<small>→NADP+</small>|}} | ||
| Line 17: | Line 17: | ||
|style="text-align:center;"|[[Image:Arrow00d.png]] | |style="text-align:center;"|[[Image:Arrow00d.png]] | ||
|- | |- | ||
|style="text-align:center;"|1-alkyl ''sn''-glycerol 3p<br/>[[Image: | |style="text-align:center;"|1-alkyl ''sn''-glycerol 3p<br/>[[Image:LBG1K3P.png]] | ||
{{Map/ReactionDown|R2-CO-CoA|CoA|[http://metabolomics.jp/wiki/Enzyme:2.3.1.51 2.3.1.51]}} | {{Map/ReactionDown|R2-CO-CoA|CoA|[http://metabolomics.jp/wiki/Enzyme:2.3.1.51 2.3.1.51]}} | ||
| | | | ||
|style="text-align:center;"|1-acyl ''sn''-glycerol 3p<br/>or lyso-phosphatidate<br/ | |style="text-align:center;"|1-acyl ''sn''-glycerol 3p<br/>or lyso-phosphatidate<br/> | ||
{{Map/ReactionDown|R2-CO-CoA|CoA|[http://metabolomics.jp/wiki/Enzyme:2.3.1.51 2.3.1.51]}} | {{Map/ReactionDown|R2-CO-CoA|CoA|[http://metabolomics.jp/wiki/Enzyme:2.3.1.51 2.3.1.51]}} | ||
|- | |- | ||
|style="text-align:center;"|1-alkyl 2-acyl ''sn''-glycerol 3p<br/>[[Image: | |style="text-align:center;"|1-alkyl 2-acyl ''sn''-glycerol 3p<br/>[[Image:LBG1K2C3P.png]] | ||
{{Map/ReactionDown|H2O|Pi|[http://metabolomics.jp/wiki/Enzyme:3.1.3.4 3.1.3.4]}} | {{Map/ReactionDown|H2O|Pi|[http://metabolomics.jp/wiki/Enzyme:3.1.3.4 3.1.3.4]}} | ||
| | | | ||
Latest revision as of 07:08, 3 July 2009
Ether Phospholipid Biosynthesis
エーテルリン脂質の生合成
dihydroxy acetone p
|
1.1.1.8 NADH NAD+ |
sn-glycerol 3p
| ||||||||||
| 1-acyl dihydroxy acetone p | 1.1.1.8 NADH NAD+ |
1-acyl sn-glycerol 3p
| ||||||||||
|
| |||||||||||
1-alkyl sn-glycerol 3p
|
1-acyl sn-glycerol 3p or lyso-phosphatidate
| |||||||||||
1-alkyl 2-acyl sn-glycerol 3p
|
1,2-diacyl sn-glycerol 3p or phosphatidate 
| |||||||||||
1-alkyl 2-acyl sn-glycerol
platelet-activating factor (PAF; 2=acetyl) |
1,2-diacyl and triacyl sn-glycerol |
